An 'important' reduction in risk of stent thrombosis with everolimus-eluting stent
Tuesday, August 30, 2011 - 10:30
in Health & Medicine
Results of the independently-funded Bern-Rotterdam cohort study provide robust evidence of an "important" reduction in overall and very late stent thrombosis. The reduction in incidence was found when a newer generation everolimus-eluting stent (EES) was compared with early generation drug-eluting stents (DES) at long-term follow-up.